S&P 500 Consumer Staples Sector SEC Filings — April 28, 2026

28-04-2026

CCEP reported Q1 2026 revenue of €5,001 million, up 6.7% as reported and 9.4% comparable FX-neutral from €4,689 million in Q1 2025, supported by strong 8.5% volume growth to 970 million unit cases and higher average daily sales. Europe revenue rose 9.1% to €3,549 million with 1.3% revenue per unit case growth, while APS revenue increased modestly 1.1% to €1,452 million but revenue per unit case declined 0.3%. Overall revenue per unit case grew 0.8% to €5.29 amid 93 consumption days versus 87 prior year.

• ·FX impact on total revenue: +€131 million
• ·FX impact on Europe revenue: +€24 million
• ·FX impact on APS revenue: +€107 million
• ·Total average daily sales: 10.43 million unit cases (Q1 2026) vs 10.27 (Q1 2025), +1.6%

28-04-2026

Kimberly-Clark reported first quarter 2026 net sales of $4.2 billion, up 2.7% from prior year with organic sales growth of 2.5% driven by 3.0% volume-plus-mix gains, though partially offset by 0.5% lower pricing and a 1.8% divestiture impact. Adjusted operating profit increased 3.7% to $732 million, supported by productivity savings and lower expenses, while adjusted EPS attributable to Kimberly-Clark rose 2.1% to $1.97; however, adjusted gross margin declined 60 basis points to 37.9%, adjusted EPS from continuing operations fell 1.2% to $1.60, and North America net sales decreased 0.6%. International Personal Care net sales grew strongly 9.1% to $1.5 billion with 4.0% organic growth.

• ·Cash provided by operations was $745 million, up from $327 million prior year.
• ·Total debt decreased to $7.1 billion from $7.2 billion at year-end 2025.
• ·Reaffirmed 2026 outlook includes mid-to-high single-digit adjusted operating profit growth and double-digit adjusted EPS from continuing operations growth on constant-currency basis.
• ·Effective tax rate 23.9% reported (26.2% adjusted) vs 23.5% (20.7% adjusted) prior year.

28-04-2026

Rising Stella Capital Pte. Ltd, a Singapore-based investment manager, filed its Form 13F-HR on April 28, 2026, disclosing equity holdings as of March 31, 2026, with a total market value of $213601262. The portfolio is concentrated in three ETFs: SPDR S&P 500 ETF Trust valued at $92658492 (142477 shares), Invesco QQQ Trust Series 1 at $91139031 (157904 shares), and iShares Bitcoin Trust ETF at $29803739 (775735 shares), all held with sole voting authority.

• ·All positions held with sole voting and disposition authority (SH SOLE).
• ·Filer's address: 9 Raffles Place #59-01 Republic Plaza, Singapore 048619.
• ·SEC file number: 028-26717.

28-04-2026

Topor & Co. Korea filed its quarterly 13F-HR report disclosing $118,249,710 in total holdings across 18 positions as of March 31, 2026. The portfolio is diversified across equity and fixed income ETFs, with top holdings including Vanguard Intl Equity Index F TT WRLD ST ETF ($31,251,053), Vanguard Index Fds S&P 500 ETF ($24,986,553), and iShares TR MSCI ACWI ETF ($18,256,123). No prior period comparisons are available in this filing.

• ·Filing covers period ending March 31, 2026, filed on April 28, 2026
• ·All holdings reported as sole discretionary with zero shared or other voting authority

28-04-2026

Controladora Vuela Compania de Aviacion, S.A.B. de C.V. (Volaris) discloses 100% equity ownership in five Mexican trusts (Banco Multiva Fidecomisos CIB/3853, 3855, 3866, 3867, 3921) for financing pre-delivery payments under its Airbus aircraft purchase agreement, with Banco Multiva assuming rights from CIBanco effective September 2, 2025. The company also reports 100% ownership in Fidecomiso CIB/3249, through which subsidiary Volaris Opco issued three series of asset-backed securities notes (15 million units each): VOLARCB 19 (Ps.1.5B or $78.5M, fully amortized June 20, 2024), VOLARCB 21L (Ps.1.5B or $72.1M), and VOLARCB 23 (Ps.1.5B or $85.8M), under CNBV-approved programs up to Ps.3.0B ($157.1M/$144.2M) and Ps.5.0B ($286.2M). Two additional 100%-owned administrative trusts (F/745291 and CIB/3081) manage shares.

• ·VOLARCB 19 notes fully amortized on June 20, 2024.
• ·Banco Multiva assumed all rights and obligations of CIBanco effective September 2, 2025.

28-04-2026

Corvex, Inc. (formerly associated with Movano Inc., ticker MOVE) filed Amendment No. 1 to its 10-K for the fiscal year ended December 31, 2025, on April 28, 2026, pursuant to General Instruction G(3) as it will not file a definitive proxy statement within 120 days of fiscal year-end. The amendment restates Part III items (Directors, Executive Compensation, Security Ownership, Related Transactions, and Accountant Fees), updates the cover page to note no incorporated documents, and adds new certifications, the 2024 Equity Incentive Plan, and a common stock description as exhibits. No financial statements or related disclosures were amended or included.

• ·Entity is a Non-accelerated Filer, Small Business, and Emerging Growth Company.
• ·Entity File Number: 001-40254; CIK: 0001734750; EIN: 82-4233771.
• ·Trading on NASDAQ under symbol MOVE.
• ·Address: 3401 North Fairfax Drive, Suite 3230, Arlington, VA 22226.
• ·Original 10-K filed March 31, 2026.

28-04-2026

Valmont Industries reported net sales of $1,029,197 thousand for the thirteen weeks ended March 28, 2026, up 6.2% YoY from $969,314 thousand, with Infrastructure segment at $803,180 thousand and Agriculture at $226,017 thousand. Operating income increased 21.3% to $155,626 thousand, driving net earnings attributable to Valmont of $108,033 thousand (diluted EPS $5.51), up 23.8% YoY. However, cash and equivalents fell $26,951 thousand to $160,189 thousand QoQ amid $57,550 thousand stock repurchases, $34,568 thousand capex, and an $11,195 thousand acquisition.

• ·Diluted EPS $5.51 vs $4.32 YoY (+27.6%)
• ·Cash dividends declared $0.77 per share (vs $0.68 prior year)
• ·131,197 shares repurchased
• ·Redeemable noncontrolling interests reduced to $9,301 thousand after $8,922 thousand purchase
• ·Income taxes paid $7,290 thousand (down from $10,672 thousand YoY)

28-04-2026

On April 22, 2026, Littelfuse, Inc. held its 2026 Annual Meeting of Stockholders, where all eight director nominees were elected with overwhelming support (For votes ranging from 21.3M to 23.0M shares). Stockholders also approved, on an advisory basis, the compensation of named executive officers (21.2M For vs. 1.8M Against) and ratified Deloitte & Touche LLP as independent auditors for fiscal year ending December 26, 2026 (23.8M For). Additionally, the Board approved updated forms of restricted stock unit and performance share award agreements under the company's long-term incentive plans, incorporating death or disability as qualifying for retirement vesting.

• ·All director elections had 785,230 broker non-votes.
• ·Annual Meeting held April 22, 2026; fiscal year ends December 26, 2026.
• ·New award agreements filed as Exhibits 10.1 (RSU under Littelfuse Plan), 10.2 (PSU under Littelfuse Plan), 10.3 (RSU under LF/IXYS Plan).

28-04-2026

UPS reported Q1 2026 consolidated revenues of $21.2B with operating profit of $1.27B (6.0% margin) and adjusted operating profit of $1.32B (6.2% margin), diluted EPS of $1.02 and adjusted EPS of $1.07. While International segment revenue grew 3.8% to $4,540M, U.S. Domestic revenue declined 2.3% to $14,125M and Supply Chain Solutions revenue fell 6.5% to $2,537M; operating profits declined in U.S. Domestic to $515M (from $979M) and International to $547M (from $641M), though Supply Chain Solutions improved to $205M (from $46M). The company reaffirms FY2026 guidance of approximately $89.7B revenue, 9.6% adjusted operating margin, $3.0B capex, and $5.4B dividends.

• ·GAAP diluted EPS of $1.02; non-GAAP adjusted diluted EPS of $1.07 for Q1 2026, including after-tax transformation charges of $42M ($0.05 per share).
• ·Achieved $600M program cost savings in Q1 2026 from Network Reconfiguration and Efficiency Reimagined; expect $3B full-year savings.
• ·Program costs incurred to date $599M as of March 31, 2026, including $55M in Q1 2026; expected non-GAAP adjusted operating expense exclusion of $1.3B-$1.5B in 2026.
• ·Initiatives expected to conclude by 2027.

28-04-2026

Ellington Financial Inc. issued a press release on April 27, 2026, announcing its estimated book value per share of common stock as of March 31, 2026, furnished under Item 7.01 to satisfy Regulation FD requirements. The press release is attached as Exhibit 99.1. No specific book value figure or period-over-period comparisons are provided in the filing.

• ·Filing signed on April 27, 2026.
• ·Principal executive offices: 53 Forest Avenue, Old Greenwich, CT 06870; Telephone: (203) 698-1200.
• ·Securities traded on The New York Stock Exchange.

28-04-2026

Aclaris Therapeutics, Inc. announced positive full top-line results from the first-in-human Phase 1a single ascending dose (SAD) and multiple ascending dose (MAD) trial of its anti-TSLP/IL-4Rα bispecific antibody ATI-052. The company also selected lichen planus (LP) as the lead indication for its selective ITK/JAK3 inhibitor ATI-2138. A conference call and presentation are scheduled for April 28, 2026, with details in Exhibits 99.1 and 99.2.

28-04-2026

Hello Group Inc. reported consolidated net revenues of RMB 10,367,096 thousand for the year ended December 31, 2025, a 1.9% decline YoY from RMB 10,562,971 thousand in 2024, while value-added services remained stable at 98.5% of revenues. Net income attributable to shareholders dropped 22.6% YoY to RMB 804,013 thousand from RMB 1,039,573 thousand, with operating margin contracting to 13.1% from 14.5% amid rising cost-to-revenue ratio to 87.3%. However, cash and cash equivalents increased 29.1% to RMB 5,320,022 thousand, bolstering liquidity.

• ·The company believes it was a PFIC for U.S. tax purposes in 2025, potentially leading to adverse tax consequences for U.S. holders.
• ·Cost of revenues increased to 62.2% of revenues in 2025 from 61.0% in 2024.
• ·Sales and marketing expenses rose to 13.2% of revenues in 2025 from 12.6% in 2024.
• ·Share of loss on equity method investments was RMB (12,879) thousand in 2025 vs income of RMB 59,216 thousand in 2024.

28-04-2026

Omnicell reported strong Q1 2026 financial results with total revenues of $310 million, up 15% YoY from $270 million, driven by connected devices, technical services, SaaS/Expert Services, and consumables. GAAP net income was $11 million ($0.25 per diluted share), swinging from a $7 million loss ($0.15 per share) YoY, while non-GAAP net income rose to $25 million ($0.55 per share) from $12 million ($0.26 per share) and non-GAAP EBITDA increased to $45 million from $24 million. The company raised FY2026 guidance, including non-GAAP EBITDA to $153-168 million and non-GAAP EPS to $1.80-2.00, reflecting disciplined cost management.

• ·Q2 2026 total revenues guidance: $307-313 million; product revenues: $174-177 million; service revenues: $133-136 million.
• ·FY2026 guidance: Product Bookings $510-560 million; Annual Recurring Revenue $680-700 million; Total Revenues $1.215-1.255 billion; Product Revenues $690-710 million; Service Revenues $525-545 million; Technical Services Revenues $260-270 million; SaaS and Expert Services Revenues $265-275 million.
• ·Showcased Omnicell Titan XT and OmniSphere at AONL 2026 Annual Meeting and 30th EAHP Congress.

28-04-2026

Asbury Automotive Group reported Q1 2026 revenue of $4.1 billion and gross profit of $727 million (17.7% margin), with GAAP net income rising 42% YoY to $188 million ($9.87 EPS) driven by a $94 million gain on divestitures of 10 dealerships (annualized revenue $625 million). However, adjusted net income fell 24% YoY to $102 million ($5.37 EPS) after excluding divestiture gains, Tekion implementation costs, weather losses, and other items, while used retail gross profit per unit grew 16% to $1,847. The company repurchased 678,000 shares for $147 million and converted over 50% of stores to Tekion amid ongoing portfolio optimization.

• ·Same store revenue of $3.5 billion and gross profit of $616 million (17.7% margin) in Q1 2026.
• ·Parts and service revenue $627 million with gross profit $365 million; F&I PVR $2,302 total / $2,307 same store.
• ·Adjusted operating margin 5.0% total / 5.3% same store Q1 2026.
• ·Transaction adjusted net leverage ratio 3.2x as of March 31, 2026.
• ·$453 million remaining on share repurchase authorization as of March 31, 2026.

28-04-2026

Coca-Cola reported strong Q1 2026 results with global unit case volume up 3%, net revenues up 12% to $12.5 billion, organic revenues up 10%, operating income up 19%, and comparable EPS up 18% to $0.86, alongside operating margin expansion to 35.0% from 32.9%. The company gained value share in total NARTD beverages globally. However, Asia Pacific operating income declined 14% (comparable currency neutral down 17%) with price/mix down 6%, juice/dairy/plant-based beverages declined 1%, and coffee volume was flat.

• ·Company gained value share in total NARTD beverages across most regions, even in Asia Pacific.
• ·Coca-Cola Zero Sugar grew 13% globally.
• ·Tea grew 38% globally.
• ·Pending sale of CCBA expected in H2 2026, impacting guidance.
• ·Six additional days in Q1 contributed to concentrate sales outpacing volume by 5 points globally.
• ·Updated FY 2026 underlying effective tax rate estimated at 19.9%.
• ·Expected 1-2% currency tailwind for comparable net revenues FY 2026.

28-04-2026

Apellis Pharmaceuticals, Inc. filed a 10-K/A amendment disclosing a 11.7% YoY increase in total auditor fees to $2,339,491 in 2025 from $2,093,952 in 2024, driven by higher audit fees (+9.7%). Executive compensation performance scorecard showed mixed results, with U.S. revenue goals (40% weighting) only partially achieved while several pipeline advancements exceeded targets. Equity compensation plans as of December 31, 2025, include 15,530,536 securities outstanding upon exercise at a weighted average price of $17.60, with 4,106,250 shares available for future issuance.

• ·2026 Annual Cash Incentive Plan elements: 50% weighted on FDA SYFOVRE prefilled syringe approval by Dec 31, 2026; 50% on cumulative U.S. EMPAVELI revenue Jul 1-Dec 31, 2026.
• ·Performance scorecard: Regulatory and Pipeline (40%) mostly exceeded; Revenue (40%) partially achieved; Operational Effectiveness (20%) mixed with some exceeded and partially achieved.
• ·Approved equity plans weighted average exercise price $17.20; non-approved $27.58.

28-04-2026

Exodus Movement, Inc. exercised its rights as a secured lender to appoint a receiver in the United Kingdom over W3C Corp. subsidiaries Monavate Holdings Limited, Monavate Limited, and Baanx Ltd. due to W3C's failure to repay amounts due under a term loan facility after demand for immediate repayment. The receiver intends to conduct a sale process of the subsidiaries' shares, with Exodus expecting to participate.

• ·Filing items: 7.01 (Regulation FD Disclosure) and 9.01 (Financial Statements and Exhibits).
• ·Date of earliest event reported: April 28, 2026.

28-04-2026

GM Financial reported first quarter 2026 net income of $514 million, up 3% YoY from $499 million and 12% QoQ from $460 million. However, total originations declined 15% YoY to $12.3 billion, with retail loan originations down 14% to $8.3 billion and operating lease originations down 19% to $4.0 billion; delinquencies also rose with 31-60 days at 2.4% (vs 2.2% YoY) and over 60 days at 0.9% (vs 0.7% YoY). Earning assets totaled $123.9 billion at quarter-end, supported by available liquidity of $35.0 billion.

• ·Allowance for loan losses as % of retail finance receivables: 3.6% at Mar 31, 2026 (up from 3.5% at Dec 31, 2025)
• ·Commercial finance receivables: $15.7B at Mar 31, 2026 (down from $16.9B at Mar 31, 2025)
• ·Revenue: $4,276M in Q1 2026 (up from $4,164M in Q1 2025)
• ·Provision for loan losses: $267M in Q1 2026 (down from $328M in Q1 2025)

28-04-2026

General Motors reported first-quarter 2026 revenue of $43.6 billion, down 0.9% YoY from $44.0 billion, and net income attributable to stockholders of $2.6 billion, down 5.7% YoY from $2.8 billion. However, EBIT-adjusted increased 21.9% YoY to $4.3 billion, adjusted EPS rose 33.0% to $3.70, and adjusted automotive free cash flow grew 56.4% to $1.3 billion despite a sharp 77.8% decline in automotive operating cash flow to $533 million. The company raised its full-year 2026 EBIT-adjusted guidance to $13.5 billion - $15.5 billion from $13.0 billion - $15.0 billion due to a $0.5 billion favorable tariff adjustment and declared a quarterly dividend of $0.18 per share.

• ·GMNA EBIT-adjusted of $3,661 million, up 11.4% YoY.
• ·GMI EBIT-adjusted of $123 million (n.m. YoY).
• ·China equity income of $165 million (n.m. YoY).
• ·GM Financial EBT-adjusted of $688 million, up 0.5% YoY.
• ·Quarterly dividend of $0.18 per share payable June 18, 2026.
• ·Cash and cash equivalents of $19,800 million as of March 31, 2026.

28-04-2026

NorthStrive Biosciences Inc., a wholly owned subsidiary of PMGC Holdings Inc. (Nasdaq: ELAB), filed a new U.S. patent application (No. 19/655,160) expanding its proprietary EL-22 myostatin-engineered probiotic technology into human pharmaceutical applications for muscle-wasting conditions such as sarcopenia, muscle disuse atrophy, and neurological disorders. The application covers specific dosing regimens and formulations, building on prior IP focused on muscle preservation and growth, including support for patients on GLP-1 receptor agonists. This strengthens NorthStrive’s intellectual property portfolio in muscle health therapeutics.

• ·U.S. Patent Application No. 19/655,160
• ·Targets muscle loss associated with GLP-1 receptor agonist weight loss treatments

28-04-2026

Lululemon athletica inc.'s preliminary proxy statement (PREC14A) details the board's April 20, 2026 approval of Heidi O’Neill as CEO effective September 8, 2026, following Calvin McDonald’s December 2025 departure and Martha Morfitt’s appointment as Executive Chair on December 11, 2025, with interim co-CEOs Meghan Frank and André Maestrini. It outlines governance practices including stockholder engagement on topics like strategy and ESG, risk oversight by board committees, and director compensation with $160,000 RSUs per non-employee director for fiscal 2025. Say-on-pay received 83% support at the 2025 annual meeting, with no program changes resulting.

• ·Directors who are CEOs of public companies limited to two additional public boards; non-executives to four.
• ·Annual say-on-pay votes to continue, with next frequency vote by 2029 annual meeting.
• ·Fiscal year end: February 2.

28-04-2026

First Commonwealth Financial Corporation (NYSE: FCF) reported Q1 2026 GAAP net income of $37.5 million ($0.37 diluted EPS), down $7.3 million or 16% QoQ from $44.9 million ($0.43 EPS) but up $4.9 million or 15% YoY from $32.7 million ($0.32 EPS). While average deposits grew $67.1 million (2.7% annualized QoQ), NIM expanded 30 bps YoY to 3.92%, and the board approved a 3.7% dividend increase to $0.14 per share, end-of-period loans fell $74.2 million (3.2% annualized QoQ), provision expense rose $3.7 million QoQ to $10.7 million, and core efficiency ratio worsened 259 bps QoQ to 55.43%. The company repurchased 1,284,457 shares at $17.67 average price, with strong capital ratios including Bank-level Total Capital at 13.8%.

• ·Loan-to-deposit ratio decreased 447 bps to 90.9% in Q1 2026.
• ·Tangible book value per share increased $0.12 (4.3% annualized QoQ).
• ·AOCI as % of tangible common equity increased 30 bps to 5.90%.
• ·Company capital ratios: Total 14.9%, Tier I 13.2%, Leverage 10.9%, CET1 12.5% at March 31 2026.
• ·Subsequent to quarter-end, two nonaccrual commercial credits totaling $5.6M (with $3.3M reserves) sold or paid off.

28-04-2026

Climb Bio, Inc. (Nasdaq: CLYM) announced a $110.0 million private placement with institutional investors, selling 9,481,000 shares of common stock at $9.50 per share and pre-funded warrants to purchase 2,106,000 shares at $9.4999 per warrant. The transaction, led by placement agents Leerink Partners and Piper Sandler, is expected to close on or about April 29, 2026, subject to customary conditions, providing gross proceeds before fees. No declines or flat metrics reported in this financing event.

• ·Expected closing date: on or about April 29, 2026
• ·SEC resale registration statement to be filed no later than 45 days after closing
• ·Pre-funded warrants exercisable immediately at $0.0001 per share, subject to beneficial ownership limits

28-04-2026

Handelsbanken Fonder AB filed its 13F-HR on April 28, 2026, for the quarter ended March 31, 2026, disclosing a portfolio of 1,491 equity positions with a total market value of $30,001,084,000. The holdings span diverse sectors including technology (e.g., Alphabet Inc. Class A and C, Apple Inc., Amazon.com Inc.), healthcare (e.g., AbbVie Inc., Amgen Inc.), and financials (e.g., Bank of America Corp.), with no prior period data provided for comparison. This neutral quarterly disclosure reflects standard institutional reporting without indicated buys, sells, or performance metrics.

• ·SEC file number: 028-17263
• ·Business address: Blasieholmstorg 12, Stockholm V7 10670
• ·Phone: +46 87011000

28-04-2026

PFA Pension, Forsikringsaktieselskab disclosed $33,244,436,442 in U.S. equity holdings across 381 positions in its 13F-HR filing as of March 31, 2026. Top holdings include Apple Inc. ($2,190,134,344), Amazon.com Inc. ($1,119,245,392), Alphabet Inc. Cap Stk Cl A ($1,004,176,662), Broadcom Inc. ($828,957,377), and Alphabet Inc. Cap Stk Cl C ($794,757,170), all with sole voting power. No changes or performance metrics were reported relative to prior periods.

• ·Filing date: April 28, 2026
• ·Report period end: March 31, 2026
• ·All listed holdings held with sole voting and sole discretionary power (SH SOLE)

28-04-2026

Commerce Bancshares Inc. (CBSH) filed an 8-K on April 28, 2026, under Items 5.02 (director/officer departures, elections, or appointments), 5.07 (submission of matters to a vote of security holders), and 8.01 (other events), indicating potential leadership changes and shareholder meeting results. No specific details on individuals involved, vote outcomes, or other events were provided in the filing metadata. No financial metrics, improvements, declines, or flat performance were reported.

• ·CIK: 0000022356
• ·SIC: 6022 - STATE COMMERCIAL BANKS
• ·Fiscal Year End: 1231
• ·Acc-no: 0000022356-26-000128
• ·File/Film Number: 001-3650226905655

28-04-2026

Schaper Benz & Wise Investment Counsel Inc/WI disclosed total holdings of $1,308,517,700 across 158 positions in its 13F-HR filing as of March 31, 2026. Top holdings include Apple ($50,240,751), Alphabet Inc. Class C ($48,859,143), Cisco Systems ($39,715,307), and Waters ($31,172,215), with all positions held under sole discretionary authority. The portfolio is diversified across technology, healthcare, financials, and ETFs with no reported changes, options, or shared voting authority.

• ·Filing submitted on April 28, 2026 for quarter ended March 31, 2026
• ·Filer CIK: 0001033974, based in Neenah, WI
• ·No put/call options or other investment discretion reported across all positions

28-04-2026

The Federal Home Loan Bank of Chicago filed an 8-K disclosing new consolidated obligation bonds for which it is the primary obligor, with trade dates of April 23 and 24, 2026, totaling $50,000,000 in par value. The issuances include a $25,000,000 bond (CUSIP 3130BAHR1) and a $15,000,000 bond (CUSIP 3130BAHR1), both maturing April 28, 2031 at 4.25% fixed rate, and a $10,000,000 bond (CUSIP 3130BAHU4) maturing April 28, 2028 at 4.12% fixed rate; all are Optional Principal Redemption Bermudan style callable bonds. No period-over-period comparisons or performance metrics were provided.

• ·All bonds settle on 4/28/2026 with next pay date 10/28/2026 and next call date 7/28/2027 (first two) or 7/28/2026 (third).
• ·Consolidated obligations are joint and several obligations of the eleven Federal Home Loan Banks, backed only by their financial resources, not guaranteed by the U.S. government.
• ·Schedule A excludes discount notes with maturity of one year or less issued in ordinary course.

28-04-2026

Duff & Phelps Investment Management Co filed its 13F-HR holdings report for the quarter ended March 31, 2026, disclosing 249 equity positions with a total market value of $9629907082. The portfolio is concentrated in utilities (e.g., Alliant Energy, Ameren), REITs (e.g., Agree Realty, Alexandria Real Estate), and energy infrastructure firms, with no reported changes or performance metrics. The report was signed by Chief Compliance Officer Kathleen Hegyi on April 27, 2026.

• ·Report covers holdings as of 2026-03-31, filed 2026-04-28.
• ·Predominantly utility and REIT-focused portfolio with sole and other manager (OTR) ownership designations.

28-04-2026

Angeles Investment Advisors, LLC filed its 13F-HR on April 28, 2026, reporting holdings as of March 31, 2026, across 31 securities, predominantly ETFs with a focus on broad market, international, value, and fixed income exposure. The largest position is Vanguard Index Fds S&P 500 ETF SHS valued at $840535339 (1406636 shares), followed by Vanguard Star Fds VG TL INTL STK F at $227002530 (2943879 shares) and Vanguard Scottsdale Fds MTG-Bkd Secs ETF at $65049225 (1385500 shares). All positions are held solely with no shared or other voting authority.

• ·Report period end date: 2026-03-31
• ·Filing CIK: 0001535695
• ·Business address: 429 Santa Monica Blvd, Suite 650, Santa Monica, CA 90401
• ·No voting authority shared or other across all holdings

28-04-2026

Federal Home Loan Bank of Des Moines disclosed the issuance of $425 million in callable bonds (total par value) traded between April 22-24, 2026, with settlement dates in late April to early May 2026. These bonds have maturities from July 2026 to November 2046, coupon rates ranging from 3.87% to 5.75%, and feature optional principal redemption in American or Bermudan styles, including fixed constant and variable single index floater types. No period-over-period comparisons or performance metrics were provided in the filing.

• ·Trade dates: April 22, 2026 (two issuances), April 23, 2026 (three issuances), April 24, 2026 (one issuance)
• ·Maturity dates: July 21, 2026; October 27, 2026; November 4, 2026; May 21, 2027; October 28, 2027; November 4, 2046
• ·First call dates: April 21, 2027; July 27, 2026; November 4, 2026; October 21, 2026; July 28, 2026
• ·CUSIPs: 3130BAGV3, 3130BAHA8, 3130BAHJ9, 3130BAHP5, 3130BAHW0

28-04-2026

Northfield Bancorp, Inc. (NFBK) discloses corporate goals including EPS of $0.86, $424.0 million in loan originations, $140.4 million in deposit growth, and $88.0 million in transaction deposit (DDA) growth. Executive all other compensation totals range from $37,879 for Ms. Tomasello to $127,554 for Mr. Klein, with breakdowns including deferred compensation contributions and automobile allowances. Equity compensation plans show 80,000 securities available upon exercise at a weighted average price of $17.67, with 1,205,988 remaining available for issuance.

• ·Gil Chapman appointed director since 2005, term expires 2028.
• ·Gil Chapman career highlights include owning Island Ford (1986-2008).
• ·Mr. Klein employer contributions to deferred plans: $83,090; Automobile: $19,739; Dividends on RSAs: $20,732; Other: $3,993.
• ·Equity compensation plans approved by security holders only.

28-04-2026

28-04-2026

28-04-2026

28-04-2026

28-04-2026

28-04-2026

28-04-2026

28-04-2026

28-04-2026

28-04-2026

28-04-2026

28-04-2026

28-04-2026